Vericel Corp Ord (VCEL)

Exchange
NASDAQ
Symbol
VCEL
Sector
Life Sciences
Industry
Biological Products, (no Disgnostic Substances)
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures, and distributes cell therapies for the sports medicine and severe burn care markets in the United States. The company is headquartered in Cambridge, Massachusetts.
Country
USA

Stock price

At close: December 19, 2025

  • Open
    35.99
  • High
    36.81
  • Low
    35.53
  • Close
    36.05
  • Volume
    1,327,350

Financial ratios

Dec 31, 2024